Open AccessS0665 Clostridium difficile Infection in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Program: An Update as of May 2019
Author(s) -
Edward V. Loftus,
Alessandro Armuzzi,
Daniel C. Baumgart,
Jeffrey R. Curtis,
Jami Kinnucan,
Nana Koram,
Leonardo Salese,
Chinyu Su,
Kenneth Kwok,
John Woolcott
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704708.98059.7d
Subject(s) - tofacitinib , medicine , ulcerative colitis , clostridium difficile , gastroenterology , cohort , incidence (geometry) , placebo , antibiotics , rheumatoid arthritis , biology , disease , microbiology and biotechnology , physics , alternative medicine , optics , pathology